Healthcare
Live Price
Offline$408.00
+0.00% today
1Y Change
+17.92%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 251 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Virbac S.A. (VRBCF) is a Healthcare stock with a market cap of $3.04B and listed on OTC. The stock last traded around $408.00 and up 17.9% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of +4.8%, EPS growth of +3.6%, a dividend yield of 0.4%. What stands out right now is revenue +4.8%, EPS +3.6%, free cash flow -16.5% with operating margin 14.9% and ROIC 10.0%. The dividend is present but secondary, with a yield around 0.4%. Valuation is more restrained than many high-expectation growth names at P/E 20.2 and price/sales 2.1. Stock Foundry combines VRBCF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
VRBCF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
VRBCF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for VRBCF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$1.1B
-12.5% YoY
FY Net Income
$113.2M
-7.2% YoY
Free Cash Flow
$82.7M
+82.2% YoY
Revenue Growth
+4.8%
EPS Growth
+3.6%
Gross Margin
35.4%
Net Margin
10.3%
Income statement
EUR
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.5B | 1.4B | 1.2B | 1.2B | 1.1B |
| Gross Profit | 518M | 938M | 810M | 795M | 713M |
| Operating Income | 218M | 227M | 185M | 180M | 168M |
| EBITDA | 278M | 276M | 231M | 218M | 208M |
| Net Income | 151M | 145M | 121M | 122M | 113M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
EUR
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 122M | 150M | 176M | 177M | 173M |
| Total Assets | 1.9B | 1.8B | 1.5B | 1.3B | 1.2B |
| Total Liabilities | 789M | 805M | 546M | 495M | 476M |
| Shareholder Equity | 1.1B | 1.0B | 900M | 839M | 725M |
| Total Debt | 295M | 307M | 120M | 90M | 94M |
| Net Debt | 173M | 157M | -56M | -87M | -78M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
130M
+31.2% YoY
Capital Expenditures
47M
+12.0% YoY
Free Cash Flow
83M
+82.2% YoY
Key ratios
Gross Margin
35.4%
Operating Margin
14.9%
Net Margin
10.3%
ROE
13.8%
Debt / Equity
0.26x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.